Clinical Trials Directory

Trials / Completed

CompletedNCT06603116

Evaluation of the Clinical Performance of Bioactive Giomer Restoration in Class II Cavities After One Year

Evaluation of the Clinical Performance of Bioactive Giomer Restoration in Class II Cavities After One Year and in Vitro Investigation of the Surface Roughness

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Faculty of Dental Medicine for Girls · Other Government
Sex
All
Age
20 Years – 30 Years
Healthy volunteers
Accepted

Summary

Assess the clinical performance of the bioactive Giomer restoration in class II cavities after one year using FDI criteria for assessment of dental restorations. Moreover, the surface roughness will be investigated in-vitro using profilometer

Detailed description

* Patients will be selected according to the following inclusion and exclusion criteria from the outpatient Operative clinic, Faculty of Dental Medicine for Girls, Al-Azhar University. * The patients will be informed about the purpose of the investigation, the clinical procedures and the advantages/risks of the applied materials and techniques. A written informed consent form will be signed from patients prior to study initiation. * Co-operative patients of age range 20-30 years old with no gender prediction, The patients will be divided into two groups Group (1): Bioactive Giomer restoration. Group (2): Nano-hybrid Composite restoration. Restoration will be evaluated using FDI criteria (functional and biological properties) All the restorations will be clinically evaluated after 1 week (baseline),3 month, 6 months,12 months. data collected and statistically analyzed

Conditions

Interventions

TypeNameDescription
OTHERtreatment of class two cavitiesrestorations in class 2 cavities

Timeline

Start date
2022-11-15
Primary completion
2022-11-22
Completion
2024-03-25
First posted
2024-09-19
Last updated
2024-09-19

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06603116. Inclusion in this directory is not an endorsement.